advisorsecurities master

IMAImageneBio, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
17023
Ticker
IMA
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2025-07-28
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
IMA

Detail

Enriched 2026-08-14 20:47

Market cap
$67,995,221.44
Shares outstanding (class)
11,351,456
Shares outstanding (weighted)
11,351,456
SIC
2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees
18
Location
SAN DIEGO, CA
Description

ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data